Rectal cancer and organ-preservation: safety first, then the king
Authors
Fernandez, LMSao Juliao, GP
Renehan, Andrew G
Beets, GL
Papoila, AL
Vailati, BB
Kranenbarg, EMK
Roodvoets, AGH
Figueiredo, NL
Van De Velde, CJH
Habr-Gama, A
Perez, RO
Affiliation
Manchester Cancer Research Centre, National Institute of Health and Research Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, United Kingdom, Colorectal and Peritoneal Oncology Centre, The Christie National Health Service Foundation Trust, Manchester, United KingdomIssue Date
2023
Metadata
Show full item recordCitation
Fernandez LM, Sao Juliao GP, Renehan AG, Beets GL, Papoila AL, Vailati BB, et al. Rectal Cancer and Organ-Preservation: Safety First, Then the King. DISEASES OF THE COLON & RECTUM. 2023 OCT;66(10):E1054-E5. PubMed PMID: WOS:001088804500013. English.Journal
Diseases Of The Colon & RectumDOI
10.1097/DCR.0000000000003020PubMed ID
37493212Additional Links
https://dx.doi.org/10.1097/DCR.0000000000003020Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1097/DCR.0000000000003020
Scopus Count
Collections
Related articles
- [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
- Authors: Wu A, Wang L, Du C, Peng Y, Yao Y, Zhao J, Zhan T, Cai Y, Li Y, Sun Y, Ji J
- Issue date: 2017 Apr 25
- Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
- Authors: Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet JE, Medich DS, Johnson CS, Oommen SC, Wolff BG, Pigazzi A, McNevin SM, Pons RK, Bleday R
- Issue date: 2015 Nov
- Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).
- Authors: Wang L, Zhang XY, Zhao YM, Li SJ, Li ZW, Sun YS, Wang WH, Wu AW, Rectal Cancer Cooperative Group of Peking University Cancer Hospital
- Issue date: 2023 Apr 1
- Is organ preservation in rectal cancer ready for prime time?
- Authors: Tekkis P, Tait D, Cunningham D, Brown G
- Issue date: 2018 Jun 23
- [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
- Authors: Wang L, Li S, Zhang X, Sun T, Du C, Chen N, Peng Y, Yao Y, Zhan T, Zhao J, Cai Y, Li Y, Wang W, Li Z, Sun Y, Ji J, Wu A
- Issue date: 2018 Nov 25